Related Experiment Video
Updated: Mar 8, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Chlorpromazine inhibits EAG1 channels by altering the interdomain coupling
Kyle Kihn1, Ze-Jun Wang2, Xi Chen2
1Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, District of Columbia; Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, Maryland; Department of Chemistry, United States Naval Academy, Annapolis, Maryland.
None:
EAG1 depolarization-activated potassium selective channels are important targets for treatment of cancer and neurological disorders. EAG1 channels are formed by a tetrameric subunit assembly with each subunit containing an N-terminal Per-Arnt-Sim (PAS) domain and C-terminal cyclic nucleotide-binding homology (CNBH) domain. The PAS and CNBH domains from adjacent subunits interact and form an intracellular tetrameric ring that regulates the EAG1 channel gating, including the movement of the voltage sensor domain (VSD) from closed to open states. Small-molecule ligands can inhibit EAG1 channels by binding to their PAS domains. However, the allosteric pathways of this inhibition are not known. Here, we combined molecular dynamics (MD) simulations, network analysis, surface plasmon resonance (SPR), and mutagenesis-coupled electrophysiology to investigate the allosteric pathways of EAG1 channel regulation by a small-molecule ligand. MD simulations and network analysis revealed that chlorpromazine, a PAS domain small-molecule binder, alters interactions between the PAS and CNBH domains. Consistent with computational predictions, chlorpromazine affected interactions between the isolated PAS and CNBH domains probed with SPR. Our network analysis also indicated that binding chlorpromazine to the PAS domain alters coupling between all major regulatory domains of EAG1, including the intracellular PAS/CNBH domain ring, VSD and pore of the channel. Interestingly, chlorpromazine binding to the PAS domain did not substantially alter Cole-Moore shift characteristic of EAG1 channels, suggesting that chlorpromazine has little effect on the VSD movement from the deep closed to opened states. This further suggests that, if chlorpromazine binding alters coupling between the PAS/CNBH domain ring, VSD, and pore, as predicted by the network analysis, these alterations occur at potential more depolarized than the ones eliciting the Cole-Moore shift. Taken together, our study provides an insight into the allosteric pathways of EAG1 channel regulation by small-molecule PAS domain binders.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G-Protein Gated Ion Channels
Sensory...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...